Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.4.1.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CL.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBF.8.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAUNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAY.1.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.25.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XADNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XABNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.1.1.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FT.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XALNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBWNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAY.1.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.19NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GY.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBF.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GA.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAY.1.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.38NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CT.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.10.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FF.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.60NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.9.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3.15NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.6.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.35NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.45NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.31NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.26NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-211.894South Korea
AY.39.1.2 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.15 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.75.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.21NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.134NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.39.1.3 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.3.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.38NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBC.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Q.2 (Alpha)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BL.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
M.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.82 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.30NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used